We are live on
!
Find out more
NED
Nancy E. Dempze Portfolio holdings
AUM
$182M
1-Year Est. Return
16.09%
This Fund
S&P 500
This Quarter
Est. Return
-0.15%
1 Year Est. Return
+16.09%
3 Year Est. Return
+59.1%
5 Year Est. Return
+78.95%
10 Year Est. Return
+300.76%
AUM
$173M
AUM Growth
-$6.08M
(-3.4%)
Cap. Flow
-$1.78M
Cap. Flow
% of AUM
-1.03%
Top 10 Holdings %
Top 10 Hldgs %
35.52%
Holding
103
New
2
Increased
26
Reduced
38
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$560K |
| 3 |
Carrier Global
CARR
|
+$481K |
| 4 |
McCormick & Company Non-Voting
MKC
|
+$458K |
| 5 |
Salesforce
CRM
|
+$373K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$651K |
| 2 |
Live Nation Entertainment
LYV
|
+$583K |
| 3 |
NVIDIA
NVDA
|
+$538K |
| 4 |
Eli Lilly
LLY
|
+$426K |
| 5 |
Entegris
ENTG
|
+$367K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.67% |
| 2 | Healthcare | 17.01% |
| 3 | Industrials | 12.24% |
| 4 | Financials | 10.88% |
| 5 | Consumer Discretionary | 10.34% |
Similar funds
RS
CFG
CFG
TFP
AFS
EMB
CIA
HWM
Nancy E. Dempze's Q4 2024 Portfolio in Review
As of Q4 2024, Nancy E. Dempze held 103 positions worth $173M, down 3.4% from $179M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Nancy E. Dempze's Q4 2024 filing shows 2 new, 26 increased, 38 reduced and 8 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 2,348 shares worth $1.38M. The largest sale was Bristol-Myers Squibb, an estimated $651K.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Industrials.
- Nancy E. Dempze's largest Q4 2024 buy was State Street SPDR S&P 500 ETF Trust: 2,348 shares worth $1.38M.
- Nancy E. Dempze added most to Vertex Pharmaceuticals in Q4 2024, an estimated $560K increase.
- Nancy E. Dempze's biggest Q4 2024 reduction was Live Nation Entertainment, cutting an estimated $583K.
- Nancy E. Dempze fully exited Bristol-Myers Squibb in Q4 2024, selling an estimated $651K.
- Nancy E. Dempze's ten largest holdings make up 36% of its $173M portfolio in Q4 2024.
- Nancy E. Dempze opened 2 new positions and closed 8 in Q4 2024.
- Nancy E. Dempze's portfolio value fell 3.4% quarter-over-quarter to $173M.
Based on Nancy E. Dempze's 13F filing for Q4 2024, filed 13 Feb 2025.